Udsxmp Medicated System Kit
Product Images NDC 83315-200

2 FDA label images from Wellbeing Medical Supply · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Udsxmp Medicated System (NDC 83315-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wellbeing Medical Supply, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structuralformula-200 (83315200 1)

Structuralformula-200 (83315200 1)
Chemical structure of the active ingredients Furosemide and Benzalkonium Chloride as depicted in the UDSxMP Medicated System. The structure includes a benzene ring with attached functional groups and relevant atoms, consistent with the molecular formula C12H11ClN2O5S and molecular weight 330.75.*
FDA Label Image

Udsxmpkit-6 (83315200 6)

Udsxmpkit-6 (83315200 6)
The image shows the UDSxMP Medicated System kit label from Wellbeing Medical Supply, an NDC 83315-200 human prescription drug labeled as a 14-panel POC toxicology medicated collection system. It includes a Furosemide 20 mg tablet label and Benzalkonium Chloride Towelette packaging from McKesson. The kit label includes manufacturer, storage instructions, and contents details, with a blue icon of a specimen cup.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.